← Leaderboards
Hanmin Lee
University Of California San Francisco
$779,763
Attributed
$3,832,231
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–15$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$3,832,231 · 3
By mechanism
U01$3,815,585 · 1
M01$16,646 · 2
Top collaborators
- N Scott Adzick3 shared
- John W. Brock3 shared
- Jack M Fletcher3 shared
- Elizabeth A Thom3 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Steven R Cummings$87,498,694
- Douglas C Bauer$12,955,739
- Katie L Stone$26,416,173
- Nancy E. Lane$24,503,745
- Joan C Lo$7,593,122
Others in their field
Top investigators on “Consent”
- David R. Weir · University Of Michigan At Ann Arbor$410,787,127
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$231,949,330
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$156,995,892
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Praduman Jain · Vignet, Inc.$102,576,382
- Richard A Gibbs · Baylor College Of Medicine$86,848,432
Research focus
ConsentAdultAffect8 Year OldAnatomyAnisotropyAreaAuditoryAge-MonthsAdaptive BehaviorsBladderBody Mass IndexBrainBrain MorphologyCatheterizationChildChild Health CareChildhoodBaseClinical CareBirthCognitive FunctionCohortCorpus Callosum
Grant awards (6)
A Follow-up of Children Enrolled in the Management of Myelomeningocele Study$1,273,963
U01 · FY2015 · HD
A Follow-up of Children Enrolled in the Management of Myelomeningocele Study$1,247,454
U01 · FY2014 · HD
A Follow-up of Children Enrolled in the Management of Myelomeningocele Study$1,294,168
U01 · FY2013 · HD
SURGERY FOR NEC IN HUMAN INFANTS: A RANDOMIZED TRIAL$1,541
M01 · FY2005 · RR
TWIN-TWIN TRANSFUSION SYNDROME TRIAL$110
M01 · FY2005 · RR
Primary peritoneal drainage vs laparotomy and bowel resection in NEC for VLBW$14,995
M01 · FY2004 · RR